Revvity plans second quarter earnings release, shares on NASDAQ in a crowded diagnostics peer group

Revvity outlines the timing of its next quarterly update while investors position the NASDAQ-listed diagnostics and life sciences stock against larger peers such as Thermo Fisher and Danaher.

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-26, 10:32.

Revvity Inc. (US76155R1086) is preparing for its next quarterly earnings release in the coming weeks. The life sciences and diagnostics specialist is listed on NASDAQ under the ticker RVTY, in a peer group that includes Thermo Fisher Scientific and Danaher as reference points for investors.

What the schedule suggests

Revvity came into its current reporting cycle after publishing first quarter 2026 figures in late April, a cadence that usually implies a second quarter update around late July or early August each year, based on its past annual rhythm and typical U.S. reporting practices.

U.S.-listed medtech and diagnostics names such as Thermo Fisher and Danaher have broadly clustered their second quarter calls between 22 July and 7 August in recent years, setting a rough sector window that investors often use to position portfolios and plan reactions to guidance and margin commentary.

How analysts frame the sector

Revvity operates in a segment where larger peers often attract the bulk of analyst attention, with houses such as Goldman Sachs, Morgan Stanley and UBS regularly commenting on demand trends for instruments, reagents and clinical testing volumes in the U.S. and Europe, providing indirect context for smaller names.

Recent sector notes from Goldman Sachs and UBS have highlighted steady to moderate growth expectations for life sciences tools and diagnostics, with particular focus on China exposure and capital spending cycles at academic laboratories and pharmaceutical customers, themes that typically spill over into discussions of companies like Revvity.

The product behind the stock

Revvity generates a large portion of its revenue from laboratory instruments and consumables used in diagnostics and life sciences research, including automated platforms for sample preparation and analysis plus the associated reagents that are consumed on a recurring basis, forming a mix of equipment sales and consumable revenue.

Where the shares trade today

The Revvity shares (US76155R1086) trade on NASDAQ, with recent indications in the area of 105.91 US dollars per share and a market capitalization in the mid-single digit billions of US dollars, based on TradingKey data as of 2026-06-26, 20:00 ET.

Key data on the Revvity shares

• Company: Revvity Inc.
• ISIN: US76155R1086
• WKN: not available
• Ticker: RVTY
• Trading venue: NASDAQ
• Price (as of 2026-06-26, 20:00): 105.91 USD
• Market cap: mid-single digit billions USD (as of 2026-06-26)
• Sector / industry: Life Sciences Tools & Services / Diagnostics
• Index membership: not in S&P 500 or NASDAQ-100
• Next earnings date: expected late July or early August 2026

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors should conduct their own research or consult a qualified advisor before making investment decisions.